CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- 4 Open-market sale CCO & Chief Strategy Officer sold 1,906 shares at $13.89 ($26,474)
- 4 Open-market sale SVP, Finance & Accounting sold 1,548 shares at an average $13.89 ($21,502)
- 4 Open-market sale Chief Medical Officer sold 9,225 shares at an average $13.88 ($128,033)
- 4 Open-market sale Chief Legal Officer sold 2,100 shares at $15.22 ($31,965)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP, Finance & Accounting acquired 8,390 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO, CBO acquired 21,900 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 21,900 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 21,900 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 36,900 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 14 · 277 filings